FDA
approval
· 2018-07-10
FDA Approved: NEOSTIGMINE — Original Application (Dr.Reddy's Laboratories Inc)
Summary
FDA approved Dr. Reddy's Laboratories' original application for neostigmine, a generic acetylcholinesterase inhibitor used to treat myasthenia gravis and to rev…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for NEOSTIGMINE (NEOSTIGMINE)